Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP252200.RAhIub-6S5DqlYD8rNqRjvEgUsiNDKl7KXcTXaiTlMN2M130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP252200.RAhIub-6S5DqlYD8rNqRjvEgUsiNDKl7KXcTXaiTlMN2M130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP252200.RAhIub-6S5DqlYD8rNqRjvEgUsiNDKl7KXcTXaiTlMN2M130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP252200.RAhIub-6S5DqlYD8rNqRjvEgUsiNDKl7KXcTXaiTlMN2M130_provenance.
- befree-2016 importedOn "2016-02-19" NP252200.RAhIub-6S5DqlYD8rNqRjvEgUsiNDKl7KXcTXaiTlMN2M130_provenance.
- NP252200.RAhIub-6S5DqlYD8rNqRjvEgUsiNDKl7KXcTXaiTlMN2M130_assertion wasGeneratedBy ECO_0000203 NP252200.RAhIub-6S5DqlYD8rNqRjvEgUsiNDKl7KXcTXaiTlMN2M130_provenance.
- NP252200.RAhIub-6S5DqlYD8rNqRjvEgUsiNDKl7KXcTXaiTlMN2M130_assertion wasDerivedFrom befree-2016 NP252200.RAhIub-6S5DqlYD8rNqRjvEgUsiNDKl7KXcTXaiTlMN2M130_provenance.
- NP252200.RAhIub-6S5DqlYD8rNqRjvEgUsiNDKl7KXcTXaiTlMN2M130_assertion SIO_000772 10318905 NP252200.RAhIub-6S5DqlYD8rNqRjvEgUsiNDKl7KXcTXaiTlMN2M130_provenance.
- NP252200.RAhIub-6S5DqlYD8rNqRjvEgUsiNDKl7KXcTXaiTlMN2M130_assertion evidence source_evidence_literature NP252200.RAhIub-6S5DqlYD8rNqRjvEgUsiNDKl7KXcTXaiTlMN2M130_provenance.
- NP252200.RAhIub-6S5DqlYD8rNqRjvEgUsiNDKl7KXcTXaiTlMN2M130_assertion description "[Using AG879, a HER2/Neu inhibitor, and PD98059, a MAP kinase inhibitor, as well as MAP kinase phosphatase-1 (MPK-1), in the transfection assay, we found that HER2/Neu could induce prostate-specific antigen (PSA), a marker for the progression of prostate cancer, through the MAP kinase pathway at a low androgen level.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP252200.RAhIub-6S5DqlYD8rNqRjvEgUsiNDKl7KXcTXaiTlMN2M130_provenance.